Your session is about to expire
← Back to Search
ASPIRE Intervention Arm for High Blood Pressure
Study Summary
This trial aims to create training guides for both patients and the clinical team to ensure that the treatment is given consistently to every patient.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals above the age of 20 eligible to participate in this recruitment for the clinical trial?
"Participants aged between 18 and 85 are sought for this research project. Notably, there are a total of 47 trials available for those younger than 18 years old, while individuals over the age of 65 have access to up to 642 trials."
Are there ongoing efforts to actively seek participants for this research study?
"The official record on clinicaltrials.gov indicates that this specific clinical investigation is actively seeking eligible participants. The trial was originally published on January 15, 2024, with the latest update posted on February 9, 2024."
What is the current number of participants undergoing examination in this clinical trial?
"The information available on clinicaltrials.gov confirms the ongoing recruitment of participants for this investigation. Initially shared on January 15, 2024, and most recently revised on February 9, 2024, the study aims to enroll a total of 40 patients from one designated site."
Is it possible for me to be enrolled as a participant in this medical study?
"The research team aims to enroll 40 individuals with hypertension, aged between 18 and 85 years. Noteworthy requirements include: being an adult of 18 years or older, having a documented history of high blood pressure for at least one year, attending a qualifying clinic visit during the recruitment phase (where blood pressure must be elevated - SBP >140mm/Hg or DBP >90mm/Hg), currently prescribed at least one antihypertensive medication, and demonstrating the capacity to provide informed consent."
Share this study with friends
Copy Link
Messenger